01 58ABBVIE
02 18CORIUM
03 1EISAI INC
01 48039009
02 48058291
03 38168209
04 38173708
05 210016372
06 210300025
07 210307379
08 210835499
09 210966936
10 211103463
11 211648214
12 211679086
13 48039009*PED
14 38168209*PED
15 38173708*PED
16 38283379
17 38283379*PED
18 48293794
19 28329752
20 28329752*PED
21 48338485
22 48338486
23 28362085
24 28362085*PED
25 18481565
26 48580858
27 28598233
28 28598233*PED
29 29993466
01 77Blank
01 28Y
02 49Blank
01 312025-11-22
02 152026-05-22
03 12026-10-04
04 42029-03-24
05 42029-09-24
06 42029-12-05
07 22037-05-26
08 102037-07-26
09 22037-09-23
10 22038-05-20
11 22038-08-11
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8173708
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8173708
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22
Patent Expiration Date : 2025-11-22
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
US Patent Number : 8362085
Drug Substance Claim :
Drug Product Claim :
Application Number : 206439
Patent Use Code : U-1641
Delist Requested : Y
Patent Use Description : MEMANTINE HCL/DONEPEZI...
Patent Expiration Date : 2025-11-22